Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis

Bone

Volumn 49, Issue 4, 2011, Pages 880-885

  Rossini, Maurizio ^a,b   Zanotti, Roberta ^a,b   Bonadonna, Patrizia ^b   Artuso, Anna ^a,b   Caruso, Beatrice ^b   Schena, Donatella ^a,b   Vecchiato, Decio ^a,b   Bonifacio, Massimiliano ^a,b   Viapiana, Ombretta ^a,b   Gatti, Davide ^a,b   Senna, Gianenrico ^b   Riccio, Annamaria ^c   Passalacqua, Giovanni ^c   Pizzolo, Giovanni ^a,b   Adami, Silvano ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Bone mineral density; Bone turnover marker; Mastocytosis; Osteoporosis; Osteosclerosis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; TRYPTASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE DENSITOMETRY; BONE DENSITY; BONE TURNOVER; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; INDOLENT SYSTEMIC MASTOCYTOSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OSTEOSCLEROSIS; PREVALENCE; SEX DIFFERENCE; SPINE FRACTURE; SPINE RADIOGRAPHY; SYSTEMIC MASTOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; DENSITOMETRY; FEMALE; FRACTURES, BONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PELVIS; SKULL; SPINE; TRYPTASES; YOUNG ADULT;

EID: 80052303003     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.004     Document Type: Article

References (40)

1. Valent P., Horny H.-P., Li C., Longley B.J., Metcalfe D.D., Parwaresch R.M., et al. Mastocytosis. World Health Organization classification of tumours: pathology and genetics in tumours of haematopoietic and lymphoid tissues 2001, 291-302. International Agency for Research and Cancer (IARC) Press, Lyon (France). E.S. Jaffee, N.L. Harris, H. Stein, J.W. Varderman (Eds.).
2. Horny H.P., Metcalfe D.D., Bennett J.M. Mastocytosis. WHO classification of tumors of hematopoietic and lymphoid tissues 2008, 54-63. International Agency for Research and Cancer (IARC), Lyon, France. 4th edn. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
3. Pardanani A., Akin C., Valent P. Pathogenesis, clinical features and treatment advances in mastocytosis. Best Pract Res Clin Haematol 2006, 19:595-615.
4. Bonadonna P., Zanotti R., Pagani M., Caruso B., Perbellini O., Colarossi S., et al. How much specific is the association between hymenoptera venom allergy and mastocytosis?. Allergy 2009, 64:1379-1382.
5. Theoharides T.C., Boucher W., Spear K. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 2002, 128:344-350.
6. Fallon M.D., Whyte M.P., Teitelbaum S.L. Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients. Hum Pathol 1981, 12:813-820.
7. Chines A., Pacifici R., Avioli L.V., Teitelbaum S.L., Korenblat P.E. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab 1991, 72:140-144.
8. Schoenaers P., De Clerck L.S., Timmermans U., Stevens W.J. Systemic mastocytosis, an unusual cause of osteoporosis. Clin Rheumatol 1987, 6:458-462.
9. Harvey J.A., Anderson H.C., Borek D., Morris D., Lukert B.P. Osteoporosis associated with mastocytosis confined to bone: report of two cases. Bone 1989, 10:237-241.
10. Lidor C., Frisch B., Gazit D., Gepstein R., Hallel T., Mekori Y.A. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res 1990, 5:871-876.
11. Floman Y., Amir G. Systemic mastocytosis presenting with severe spinal osteopenia and multiple compression fractures. J Spinal Disord 1991, 4:369-373.
12. Brumsen C., Papapoulos S.E., Lentjes E.G.W.M., Kluin P.M., Hamdy N.A.T. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 2002, 31:556-561.
13. Johanson C., Roupe G., Lindstedt G., Mellstrom D. Bone density, bone markers and bone radiological features in Mastocytosis. Age Ageing 1996, 25:1-7.
14. Lim A.Y., Ostor A.J., Love S., Crisp A.J. Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 2005, 64:965-966.
15. Kushnir-Sukhov N.M., Brittain E., Reynolds J.C., Akin C., Metcalfe D.D. Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis. Int Arch Allergy Immunol 2006, 139:265-270.
16. Salles M., Holgado S., Navarro J.T., Ribera J.M., Riera E., Millà F., et al. Osteoporosis as a first manifestation of systemic mastocytosis. Study of 6 cases. Med Clin (Barc) 2007, 128:216-218.
17. King J.J., Crawford E.A., Iwenofu O.H., Fox E.J. Pathologic long bone fracture in a patient with systemic mastocytosis. Clin Orthop Relat Res 2007, 459:263-269.
18. Donker M.L., Bakker N.A., Jaspers W.J., Verhage A.H. Two patients with osteoporosis:initial presentation of systemic mastocytosis. J Bone Miner Metab 2008, 26:199-202.
19. Stein J.A., Kamino H., Walters R.F., Pomeranz M.K. Mastocytosis with urticaria pigmentosa and osteoporosis. Dermatol Online J 2008, 14:2.
20. Mathew R., Dhillon V., Shepherd P. Systemic mastocytosis presenting as osteoporosis-a case report. Clin Rheumatol 2009, 28:865-866.
21. Manara M., Varenna M., Cantoni S., Parafioriti A., Gallazzi M.B., Sinigaglia L. Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: a report of two cases. Clin Exp Rheumatol 2010, 28:97-100.
22. Alvarez-Twose I., Gonzalez de Olano D., Sanchez-Munoz L., Matito A., Esteban-Lopez M.I., Vega A., et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 2010, 125:1269-1278.
23. Delling G., Ritzel H., Werner M. Histological characteristics and prevalence of secondary osteoporosis in sistemic mastocytosis. A retrospective analysis of 158 cases. Pathologe 2001, 22:132-140.
24. Barete S., Assous N., de Gennes C., Granpeix C., Feger F., Palmerini F., et al. Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 2010, 69:1838-1841.
25. Reinacher-Schick A., Petrasch S., Longley B.J., Teschendorf C., Graeven U., Schmiegel W. c-Kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease. Ann Hematol 1998, 77:131-134.
26. Bonadonna P., Perbellini O., Passalacqua G., Caruso B., Colarossi S., Dal Fior D. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and raised serum tryptase. J Allergy Clin Immunol 2009, 123:680-686.
27. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study Group. Osteoporos Int 1994, 4:368-381.
28. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
29. Lewiecki E.M., Gordon C.M., Baim S., Leonard M.B., Bishop N.J., Bianchi M.L. International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone 2008, 43:1115-1121.
30. Dobigny C., Saffar J.L. H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 1997, 173:10-18.
31. De Gennes C., Kuntz D., de Vernejoul M.C. Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop Relat Res 1992, 279:281-291.
32. Metcalfe D.D. Mast cells and mastocytosis. Blood 2008, 112:946-955.
33. Biosse-Duplan M., Baroukh B., Dy M., de Vernejoul M.C., Saffar J.L. Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol 2009, 174:1426-1434.
34. Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Bone mineralisation in cystic fibrosis 2007, Cystic Fibrosis Trust. http://www.cftrust.org.uk.
35. Valent P., Akin C., Escribano L., Fodinger M., Hartmann K., Brockow K., et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007, 37:435-453.
36. Zanotti R., Bonadonna P., Bonifacio M., Artuso A., Schena D., Rossini M., et al. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica 2011, 96:482-484.
37. Cundy T., Beneton M.N., Darby A.J., Marshall W.J., Kanis J.A. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987, 8:149-155.
38. Fitzpatrick L.A., Buzas E., Gagne T.J., Nagy A., Horvath C., Ferencz V., et al. Targeted deletion of histamine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci U S A 2003, 100:6027-6032.
39. Morin S., Leslie W.D. High bone mineral density is associated with high body mass index. Osteoporos Int 2009, 20:1267-1271.
40. Chiappetta N., Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006, 36:32-36.